-
Outstanding Scientific Achievement Award lecturer highlights evolution of unimolecular therapies
Timo D. Müller, PhD, shared his insights on hormonal control of metabolism by glucose-dependent insulinotropic polypeptide (GIP) and next-generation incretin-based polyagonists during a session recognizing his contributions to diabetes and metabolic research.
-
Oral small-molecule GLP-1 RA improves blood glucose and weight reduction
The VISTA and SOLSTICE phase 2b trials evaluated the use of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) elecoglipron in adults. Melanie Davies, CBE, MBChB, MD, FRCP, FRCGP, FMedSci, and Vanita R. Aroda, MD, shared the latest study data.
Scientific Sessions Newsmakers
-
Experts share the latest updates on the Standards of Care in Overweight and Obesity
The growing document provides evidence-based, unified guidance and actionable recommendations. Leigh Perreault, MD, presented a new chapter on screening diagnosis. Louis J. Aronne, MD, FACP, shared a new chapter on obesity medications.
-
Expert panel addresses GLP-1 RAs’ factors, features, and future
Amid increasing attention for GLP-1 RAs, a panel of experts summarized a broad spectrum of topics related to these medications, including emerging pharmacological options, muscle physiology, obesity treatment for osteoarthritis, and nutritional counseling.
-
Kelly West lecturer outlines next steps for more precise definitions, preventions, and treatments for type 2 diabetes
Mohammed K. Ali, MD, MSc, MBA, who was being honored for his contributions to diabetes epidemiology, said the field is poised to move beyond a “one-size-fits-all” approach to diabetes public health policies.
-
Speakers map the knowns, unknowns, and value of understanding diversity among people living with diabetes
Sherita Hill Golden, MD, MHS, and other presenters examined what needs to be done in diabetes care to better understand and provide treatment for the nation’s increasingly racially and ethnically diverse populations living with the disease.
-
Innovation Challenge elevates creative solutions to diabetes challenges
Leaders of three start-up ventures pitched their novel product ideas at the Scientific Sessions and exited with connections for opportunities to accelerate their visions for redefining diabetes care and treatment.
-
President of Medicine & Science calls for unifying biomedical science and social determinants of care
A. Enrique Caballero, MD, highlighted the progress advancing diabetes treatment and management while shedding light on existing gaps in care and advocating for integrating advances in science into the real-world context in which people live.
Presenter Profiles
